Detalhe da pesquisa
1.
Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study.
Br J Cancer
; 118(11): 1502-1512, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29755120
2.
The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma.
Int J Cancer
; 139(1): 153-63, 2016 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26910568
3.
Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma.
Oncotarget
; 6(34): 35247-62, 2015 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26497213
4.
Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.
Cancer Discov
; 4(2): 216-31, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24436047
5.
Hepatitis C virus-induced secretion of inflammatory chemokines preferentially recruits NKG2A+CD8+ T cells.
J Infect Dis
; 198(2): 213-7, 2008 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18500933